• Season 3 - Ep.2: The why and how of MRAs in Heart Failure - Managing electrical storm

  • Oct 10 2024
  • Length: 23 mins
  • Podcast

Season 3 - Ep.2: The why and how of MRAs in Heart Failure - Managing electrical storm

  • Summary

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    • Cardiology This Week: A concise summary of recent studies
    • The why and how of MRAs in Heart Failure
    • Managing electrical storm
    • Mythbusters: garlic protects from the heart

    Host: Perry Elliott

    Guests: Carlos Aguiar, Sana Al-Khatib, Rudolf de Boer

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1792

    Disclaimer

    ESC TV Today is supported by Bristol Myers Squibb.

    This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Sana Al-Khatib and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi Aventis, Novo Nordisk, Terumo.

    Rudolf de Boer has declared to have potential conflicts of interest to report: direct research funding from European Research Council (ERC), Netherlands Heart Foundation, Fondation leDucq, Netherlands Organization for Scientific Research. Research funding to department or institution: AstraZeneca, Abbott, Boehringer Ingelheim, Cardior Pharmaceuticals GmbH, NovoNordisk. Direct fees from Abbott, AstraZeneca, Cardior Pharmaceuticals GmbH, NovoNordisk, Roche Diagnostics. Fees to department or institution: NovoNordisk.

    Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics, AstraZeneca, Forbion.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc., Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Season 3 - Ep.2: The why and how of MRAs in Heart Failure - Managing electrical storm

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.